Better analgesia from pelvic plexus block in prostate biopsy

Better analgesia from pelvic plexus block in prostate biopsy
Compared with periprostatic nerve block, pelvic plexus block, performed under Doppler ultrasound guidance, provides better pain relief for men during office-based transrectal ultrasound-guided prostate biopsy, according to research published in the August issue of The Journal of Urology.

(HealthDay) -- Compared with periprostatic nerve block (PNB), pelvic plexus block (PPB), performed under Doppler ultrasound guidance, provides better pain relief for men during office-based transrectal ultrasound-guided prostate biopsy, according to research published in the August issue of The Journal of Urology.

Francesco Cantiello, M.D., of Magna Graecia University of Catanzaro in Italy, and colleagues conducted a single-center, prospective study involving 180 patients who were randomized to receive intrarectal local anesthesia plus either PPB or PNB prior to undergoing office-based transrectal ultrasound-guided . Local anesthesia consisted of lidocaine 1.5 percent plus nifedipine 0.3 percent cream. PPB consisted of 2.5 mL lidocaine 1 percent plus naropine 0.75 percent injected on each side of the pelvic neurovascular plexus lateral to the seminal vesicle tip. Periprostatic nerve block consisted of the same mixture but was injected on each side of the neurovascular bundles at the prostate-bladder-seminal vesicle. Patients rated the level of pain/discomfort after the procedure.

The researchers found that there was no difference in noted by patients during probe introduction or administration of either the PPB or PNB. However, during the biopsy, pain was statistically significantly lower for patients who received the PPB, and this trend continued until 30 minutes following biopsy completion. No major complications were experienced.

"In conclusion, PPB under guidance provides better analgesia than PNB during office-based transrectal ultrasound-guided prostate biopsy," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Ebola: Five questions about the killer virus

47 minutes ago

The highly contagious Ebola virus, which has killed more than 4,500 people in west Africa since December and has fueled global alarm, is among the most dangerous ever identified.

Ebola fear, monitoring eases for some in Dallas

57 minutes ago

The people closest to Ebola victim Thomas Eric Duncan are trying to resume their lives now that they have come out of a 21-day incubation period without developing symptoms of the disease.

Third UN employee dies from Ebola

1 hour ago

A UN staff member in Sierra Leone has died from Ebola, the third employee from the world organization to succumb to the deadly virus, the UN spokesman said Monday.

Canadian Ebola vaccine sent to WHO for testing

1 hour ago

The first batch of an experimental Ebola vaccine developed by Canadian scientists was sent to Switzerland on Monday for testing by the World Health Organization, officials said.

User comments